Shared Medical Appointments: An Academic-Community Partnership to Improve Care Among Adults With Type 2 Diabetes in California Central Valley Region.
Academic Medical Centers
Adult
California
Community Health Services
Diabetes Mellitus, Type 2
/ blood
Female
Glycated Hemoglobin
/ analysis
Hispanic or Latino
/ statistics & numerical data
Humans
Male
Middle Aged
Non-Randomized Controlled Trials as Topic
Patient Acceptance of Health Care
/ statistics & numerical data
Primary Health Care
/ methods
Prospective Studies
Quality Improvement
Retrospective Studies
Shared Medical Appointments
Treatment Outcome
Journal
The Diabetes educator
ISSN: 1554-6063
Titre abrégé: Diabetes Educ
Pays: United States
ID NLM: 7701401
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
pubmed:
3
3
2020
medline:
15
1
2021
entrez:
3
3
2020
Statut:
ppublish
Résumé
The purpose of the study was to evaluate the effectiveness of ALDEA (Latinos con Diabetes en Acción), a Shared Medical Appointment (SMA) intervention, compared to usual primary care (UPC) for the treatment of adults with type 2 diabetes over a 6-month period. It was hypothesized that participants in the SMA will have greater reductions in A1C at 6 months post-intervention compared to the control group. This study was a quasi-experimental design with a non-randomized matched control group that followed participants prospectively for 6 months. All adults living with type-2 diabetes receiving primary care at a 2 FQHC clinics were eligible for inclusion. Participants in the control group were matched retrospectively on baseline A1C and age. The reductions in A1C were greater in the ALDEA SMA intervention group relative to the UPC control group at 6 months in both of the FQHC centers and in the combined sample. This study demonstrated that patients in the ALDEA program had a significantly greater reduction in A1C at 6 months compared to the control group. Despite its limitations, the ALDEA SMA program was successful in empowering patients and improving glycemic control.
Identifiants
pubmed: 32114939
doi: 10.1177/0145721720906792
doi:
Substances chimiques
Glycated Hemoglobin A
0
hemoglobin A1c protein, human
0
Types de publication
Clinical Trial
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng